Racial Disparities in Treatment and Outcomes Among Patients With TP53‐Mutated AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia
Cancer 2022 Dec 21;[EPub Ahead of Print], T Badar, MR Litzow, RM Shallis, A Patel, AN Saliba, M Burkart, JP Bewersdorf, M Stahl, GS De Camargo Correia, GS Guru Murthy, Y Abaza, A Duvall, D Bradshaw, V Kota, S Dinner, AD Goldberg, N Palmisiano, A Al Kali, E AtallahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.